` CEVI (CellaVision AB) vs OMX Stockholm 30 Comparison - Alpha Spread

CEVI
vs
OMX Stockholm 30

Over the past 12 months, CEVI has underperformed OMX Stockholm 30, delivering a return of -24% compared to the OMX Stockholm 30's 6% drop.

Stocks Performance
CEVI vs OMX Stockholm 30

Loading
CEVI
OMX Stockholm 30
Add Stock

Performance Gap
CEVI vs OMX Stockholm 30

Loading
CEVI
OMX Stockholm 30
Difference

Performance By Year
CEVI vs OMX Stockholm 30

Loading
CEVI
OMX Stockholm 30
Add Stock

Competitors Performance
CellaVision AB vs Peers

OMX Stockholm 30
CEVI
ABT
ISRG
BSX
SYK
Add Stock

CellaVision AB
Glance View

Market Cap
3.9B SEK
Industry
Health Care

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CEVI Intrinsic Value
257.21 SEK
Undervaluation 36%
Intrinsic Value
Price
Back to Top